José Carlos Nicolau - Researcher Profile

Publications

2 shown

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

John J.V. McMurray , Scott D. Solomon , Silvio E. Inzucchi +35 more

BACKGROUND In patients with type 2 diabetes, inhibitors of sodium-glucose cotransporter 2 (SGLT2) reduce the risk of a first hospitalization for heart failure, possibly through ...

2019 New England Journal of Medicine 6238 citations

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Paul M. Ridker , Giulia Renda , Tom Thurén +25 more

Antiinflammatory therapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent ...

2017 New England Journal of Medicine 8436 citations

Frequent Co-Authors

Identifiers

ORCID: 0000-0002-9680-3689

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.

Publications

Frequent Co-Authors

Researcher Info

External Links

Identifiers

Impact Metrics